Genetic polymorphism associated with lung cancer progression

Genetic polymorphisms associated with cancer progression lead to variations in gene expression and may serve as prognostic markers for lung cancer, researchers show. They found that in patients with lung cancer, a single nucleotide polymorphism (SNP) may regulate gene and protein expression and be associated with poor prognosis. To establish this genetic polymorphism as a useful clinical prognostic marker and to further clarify its molecular mechanism, large-scale clinicopathological studies of lung cancer and/or other types of cancer are required for additional insights.  (Mehr in: Cancer News — ScienceDaily)